SecBot SecBot
8-K ·Filed Aug 14, 2026

FOCL

EDAP TMS SA
BEARISH
Impact 6/10
Horizonimmediate Processed3mo ago SEC0001104659-26-096209
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight ▼ Bearish

The dilutive secondary offering will increase share count by ~22.5%, likely putting near-term downward pressure on the stock. Monitor the stock for typical negative price reaction around the offering close. The lock-up agreements may limit insider selling for 90 days, but the underwriter option overhang could weigh on sentiment.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.76
T+0 close · Aug 14, 2026 · via day close
Latest settled
−26.05%
T+60 · $3.52
Vs SPY
−23.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 14 $4.76entry
  2. T+1 · 3mo ago −8.40%α −7.93% · $4.36
  3. T+5 · 3mo ago −13.24%α −11.87% · $4.13
  4. T+20 · 2mo ago −13.66%α −11.66% · $4.11
  5. T+60 · 8d ago −26.05%α −23.00% · $3.52

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

EDAP TMS S.A. (FOCL) entered into an underwriting agreement for a public offering of 8,425,000 ADSs at $4.75 per ADS, with an underwriter option for up to an additional 1,263,750 ADSs. Net proceeds are expected to be approximately $37.1 million, which will be used for operating costs, capital expenditures, and general corporate purposes. The offering represents roughly 22.5% dilution relative to the current market cap and is expected to close on August 14, 2026.

Key Facts

  • Underwritten public offering of 8,425,000 ADSs at $4.75 per ADS
  • Underwriters have a 30-day option to purchase up to an additional 1,263,750 ADSs
  • Net proceeds expected to be approximately $37.1 million
  • Offering expected to close on August 14, 2026
  • Underwriters include TD Securities, Mizuho Securities, H.C. Wainwright, and Lucid Capital Markets
  • Executive officers and directors entered into 90-day lock-up agreements
  • Shares issued via capital increase without preemptive subscription rights

Financial Impact

Dilution of approximately 22.5% based on current market cap of $178M; gross proceeds of ~$40.0M before expenses, net proceeds ~$37.1M

dilutionshare count

Risk Factors

  • Significant dilution to existing shareholders
  • Potential downward price pressure from the offering
  • Proceeds used for general corporate purposes may not be value-accretive

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
73% bullish (11 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-096209
Document: tm2622525d4_8k.htm0001104659-26-096209
Document: tm2622525d4_ex5-1.htm0001104659-26-096209
Document: 0001104659-26-096209-index-headers.html0001104659-26-096209
Document: 0001104659-26-096209-index.html0001104659-26-096209
Document: 0001104659-26-096209.txt0001104659-26-096209

US Market Status

Market Closed · Opens Wed (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026